Insider · CIK 0001967168
Samuel Kintz
Files at ELVN (Enliven Therapeutics, Inc.). First filing Oct 22, 2024, latest Jun 18, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ELVN: Enliven Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 34Weak | Enliven Therapeutics, Inc. | $277k 12,500 shares | -1% | +46% from low-26% from high | |
| 31Weak | Enliven Therapeutics, Inc. | $150k 7,500 shares | -1% | +47% from low-26% from high | |
| 29Weak | Enliven Therapeutics, Inc. | $82k 5,000 shares | -1% | +13% from low-43% from high | |
| 31Weak | Enliven Therapeutics, Inc. | $150k 7,500 shares | -1% | +33% from low-33% from high | |
| 29Weak | Enliven Therapeutics, Inc. | $82k 5,000 shares | -1% | +11% from low-44% from high | |
| 33Weak | Enliven Therapeutics, Inc. | $260k 12,500 shares | -1% | - | |
| 25Weak | Enliven Therapeutics, Inc. | $28k 924 shares | -0% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 17, 2025 | ELVN Enliven Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -10,502 | $22.08 | $232k | 954,890 | Jun 18, 2025 |
| Jun 17, 2025 | ELVN Enliven Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -1,998 | $22.75 | $45k | 952,892 | Jun 18, 2025 |
| Jun 3, 2025 | ELVN Enliven Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -7,500 | $20.05 | $150k | 965,392 | Jun 5, 2025 |
| May 19, 2025 | ELVN Enliven Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -5,000 | $16.49 | $82k | 972,892 | May 21, 2025 |
| May 1, 2025 | ELVN Enliven Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -5,330 | $20.08 | $107k | 980,062 | May 5, 2025 |
| May 2, 2025 | ELVN Enliven Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -2,170 | $20.00 | $43k | 977,892 | May 5, 2025 |
| Apr 17, 2025 | ELVN Enliven Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -5,000 | $16.42 | $82k | 985,392 | Apr 21, 2025 |
| Mar 17, 2025 | ELVN Enliven Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -12,500 | $20.83 | $260k | 990,392 | Mar 19, 2025 |
| Feb 6, 2025 | ELVN Enliven Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +490,000 | $0.00 | $0 | 490,000 | Feb 10, 2025 |
| Oct 18, 2024 | ELVN Enliven Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -924 | $30.00 | $28k | 1,002,892 | Oct 22, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.